PHASE-II TRIAL OF (META-AMSA) 4'-9-(ACRIDINYLAMINO)-METHANESULFON-META-ANISIDE IN PRIMARY LIVER-CANCER

被引：8

作者：

CHENG, E

LIGHTDALE, C

YOUNG, C

YAGODA, A

FORTNER, J

GOLBEY, R

机构：

[1] MEM SLOAN KETTERING CANC CTR,DEPT MED,SOLID TUMOR SERV,NEW YORK,NY 10021

[2] MEM SLOAN KETTERING CANC CTR,DEPT SURG,NEW YORK,NY 10021

[3] MEM SLOAN KETTERING CANC CTR,DEPT MED,GASTROINTESTINAL SERV,NEW YORK,NY 10021

[4] MEM SLOAN KETTERING CANC CTR,DEPT MED,GASTR & MIXED TUMOR SERV,NEW YORK,NY 10021

[5] MEM SLOAN KETTERING CANC CTR,DEPT MED,DEV CHEMOTHERAPY SERV,NEW YORK,NY 10021

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1983年 / 6卷 / 02期

关键词：

D O I：

10.1097/00000421-198304000-00013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：211 / 213

页数：3

共 15 条

[1]

ARLIN ZA, 1980, CANCER RES, V40, P3304

[2] EXPERIMENTAL ANTITUMOR PROPERTIES OF 3 CONGENERS OF ACRIDYLMETHANESULFONANILIDE (AMSA) SERIES [J].

CAIN, BF ;

ATWELL, GJ .

EUROPEAN JOURNAL OF CANCER, 1974, 10 (08) :539-549

[3]

CYSYK RL, 1977, DRUG METAB DISPOS, V5, P579

[4]

FALKSON G, 1981, CANCER CHEMOTH PHARM, V6, P127

[5] THERAPEUTIC APPROACHES TO HEPATOMA [J].

FALKSON, G .

CANCER TREATMENT REVIEWS, 1975, 2 (01) :73-76

[6] TREATMENT OF PRIMARY AND SECONDARY LIVER CANCER BY HEPATIC-ARTERY LIGATION AND INFUSION CHEMOTHERAPY [J].

FORTNER, JG ;

MULCARE, RJ ;

SOLIS, A ;

WATSON, RC ;

GOLBEY, RB .

ANNALS OF SURGERY, 1973, 178 (02) :162-172

[7]

IHDE DC, 1977, CANCER TREAT REP, V61, P1385

[8]

KENNEDY PS, 1977, CANCER, V39, P1930, DOI 10.1002/1097-0142(197705)39:5<1930::AID-CNCR2820390503>3.0.CO

[9]

2-7

[10]

LEGHA SS, 1978, CANCER RES, V38, P4712

← 1 2 →